Table 1.
Patients demographics and operative characteristics
Group C | Group R | P | |
---|---|---|---|
Age (years) | 46.54 ± 12.93 | 49.54 ± 11.99 | 0.390 |
Gender:Male/Female | 7/19 | 6/20 | 0.749 |
ASA classification (I/II) | 7/19 | 9/17 | 0.548 |
Height (cm) | 164.31 ± 6.20 | 165.08 ± 6.37 | 0.661 |
Weight (kg) | 62.65 ± 10.74 | 66.38 ± 0.96 | 0.221 |
Operation time(min) | 88.35 ± 36.46 | 104.54 ± 46.43 | 0.168 |
Anesthesia time (min) | 107.42 ± 39.90 | 122.92 ± 48.52 | 0.214 |
Categorical variables were presented as numbers and percentage, quantitative variables were shown as means and standard deviation. ASA American Society of Anesthesiologists. Group R: the patients were recieved 6 ml of 0.75% ropivacaine for throat, glottic area and tracheal mucosa uniform spray; Group C: the patients were recieved with 6 ml of saline for throat, glottic area and tracheal mucosa uniform spray as control